Page last updated: 2024-10-31

mitoxantrone and T-Cell Lymphoma

mitoxantrone has been researched along with T-Cell Lymphoma in 9 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"We treated elderly patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) using a CMD (CPT-11, mitoxantrone [MIT], dexamethasone [DEX]) regimen and studied its safety and efficacy."9.12Phase II study of the irinotecan (CPT-11), mitoxantrone and dexamethasone regimen in elderly patients with relapsed or refractory peripheral T-cell lymphoma. ( Bessho, M; Higashihara, M; Kohori, M; Niitsu, N, 2007)
"Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare lymphoma."5.35Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma. ( Chim, CS; Kwong, YL; Loong, F; Ng, WK, 2008)
"We treated elderly patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) using a CMD (CPT-11, mitoxantrone [MIT], dexamethasone [DEX]) regimen and studied its safety and efficacy."5.12Phase II study of the irinotecan (CPT-11), mitoxantrone and dexamethasone regimen in elderly patients with relapsed or refractory peripheral T-cell lymphoma. ( Bessho, M; Higashihara, M; Kohori, M; Niitsu, N, 2007)
"Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare lymphoma."1.35Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma. ( Chim, CS; Kwong, YL; Loong, F; Ng, WK, 2008)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chim, CS1
Loong, F1
Ng, WK1
Kwong, YL2
Kouzaki, H1
Kitanishi, T1
Kitano, H1
Suzuki, M1
Au, WY1
Chan, LC1
Liang, R1
Niitsu, N1
Kohori, M1
Higashihara, M1
Bessho, M1
Kohda, K1
Tsuji, A1
Takayanagi, N1
Takeda, M1
Hayashi, S1
Takimoto, R1
Fujisaki, Y1
Tsuji, Y1
Ezoe, A1
Nakazawa, O1
Behrendt, H1
Massar, CG1
van Leeuwen, EF1
Satoh, T1
Tsushima, K1
Hizawa, Y1
Nakui, Y1
Itoh, J1
Tamura, Y1
Saitoh, S1
Taka-mi, H1
Munakata, A1
Kawamura, S1
Roussou, P1
Ilias, I1
Foufopoulou, E1
Orlandi, E1
Lazzarino, M1
Bernasconi, P1
Astori, C1
Bernasconi, C1

Trials

3 trials available for mitoxantrone and T-Cell Lymphoma

ArticleYear
Phase II study of the irinotecan (CPT-11), mitoxantrone and dexamethasone regimen in elderly patients with relapsed or refractory peripheral T-cell lymphoma.
    Cancer science, 2007, Volume: 98, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dexamethasone; Disease-Free Surv

2007
[NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:14

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto

1993
Mitoxantrone is effective in treating childhood T-cell lymphoma/T-cell acute lymphoblastic leukemia.
    Cancer, 1995, Jul-15, Volume: 76, Issue:2

    Topics: Antineoplastic Agents; Child; Child, Preschool; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T

1995

Other Studies

6 other studies available for mitoxantrone and T-Cell Lymphoma

ArticleYear
Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma.
    American journal of clinical dermatology, 2008, Volume: 9, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Humans; Lymphoma, T-Ce

2008
Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
    Auris, nasus, larynx, 2004, Volume: 31, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cycloph

2004
Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
    American journal of hematology, 2006, Volume: 81, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Humans

2006
[Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedul

1997
Onycholysis after chemotherapy in a patient with lymphoma.
    Acta dermato-venereologica, 1998, Volume: 78, Issue:4

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Finge

1998
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
    Haematologica, 1998, Volume: 83, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleo

1998